Advertisement

Increased regional market competition is associated with a lower threshold for revascularization in asymptomatic carotid artery stenosis

Published:August 04, 2022DOI:https://doi.org/10.1016/j.avsg.2022.07.008

      Abstract

      Objectives

      Revascularization practices with respect to asymptomatic carotid stenosis (ACAS) are known to vary widely among proceduralists. In addition, regional market competition has been previously shown to drive more aggressive practices in a number of surgical procedures. The aim of our study was to examine the association of regional market competition with revascularization thresholds for ACAS.

      Methods

      All patients undergoing carotid revascularization in the Vascular Quality Initiative carotid endarterectomy and stenting databases (2016-2020) were included. High-grade carotid stenosis was defined as ≥80%. We calculated the Herfindahl-Hirschman Index (HHI; a measure of physician market competition) for each US region as defined by the US Department of Health and Human Services. Logistic regression was used to examine the association of degree of carotid stenosis at revascularization with HHI stratified by symptomatology, adjusting for age, sex, race, insurance, and revascularization modality.

      Results

      Of 92,243 carotid interventions, 57,094 (61.9%) were performed for ACAS and 35,149 (38.1%) were performed for symptomatic carotid stenosis (SCAS). ACAS patients undergoing revascularization for moderate-grade stenosis were significantly less likely to be aspirin (85.6% vs. 86.3%), clopidogrel (41.3% vs. 45.1%), dual anti-platelet therapy (35.9% vs. 39.2%) and systemic anticoagulants (10.9 vs. 11.7%) compared to high-grade stenosis (all p<0.05). Multivariable analysis demonstrated that decreased local market competition was independently associated with a lower odds of revascularization for moderate versus high-grade ACAS (OR:0.99 per 10 point increase in HHI, 95%CI:0.98-0.99). There was no association of local market competition with degree of carotid stenosis at time of revascularization among patients with SCAS (OR:1.00 per 10 point increase in HHI, 95%CI:0.99-1.00). Among ACAS patients, patients with moderate-grade stenosis had a higher odds ratio of in-hospital stroke or death compared to patients with high-grade stenosis (OR:1.22, 95%CI 1.03-1.45). This association was not redemonstrated in the SCAS group (OR:0.92, 95%CI:0.80-1.06).

      Conclusions

      Increased local market competition is associated with a lower threshold for revascularization of ACAS. There is no association between regional market competition and revascularization threshold for SCAS. These findings, combined with the significantly increased risk of perioperative stroke/death among moderate-grade ACAS patients, suggest that competition among proceduralists may result in a higher tolerance for increased operative risk in patients who might otherwise be reasonable candidates for surveillance.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Annals of Vascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study.
        JAMA. 1995; 273: 1421-1428
        • Hobson 2nd, R.W.
        • Weiss D.G.
        • Fields W.S.
        • Goldstone J.
        • Moore W.S.
        • Towne J.B.
        • et al.
        “Efficacy of carotid endarterectomy for asymptomatic carotid stenosis.” The Veterans Affairs Cooperative Study Group.
        N Engl J Med. 1993; 328: 221-227
        • Bissacco D.
        • Carmo M.
        • Barbetta I.
        • Dallatana R.
        • Settembrini P.G.
        “Medical Therapy Before Carotid Endarterectomy: Changes Over a 13-Year Period and Comparison Between Asymptomatic and Symptomatic Patients.
        Angiology. 2018; 69: 113-119
        • Halliday A.
        • Harrison M.
        • Hayter E.
        • Kong X.
        • Mansfield A.
        • Marro J.
        • et al.
        “10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial.”.
        Lancet. 2010; 376: 1074-1084
        • Abbott A.L.
        “Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis.”.
        Stroke. 2009; 40: e573-e583
        • Bubulia R.
        • Halliday A.
        “The asymptomatic carotid surgery trial (ACST-2): an ongoing randomised controlled trial comparing carotid endarterectomy with carotid artery stenting to prevent stroke.”.
        Health Technol Assess. 2017; 21: 1-40
      2. ClinicalTrials.gov. Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2). Available from: https://clinicaltrials.gov/ct2/show/NCT02089217. Accessed May 9, 2021.

        • AbuRahma A.F.
        • Avgerinos E.D.
        • Chang R.W.
        • Darling 3rd, R.C.
        • Duncan A.A.
        • Forbes T.L.
        • et al.
        “Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease.”.
        J Vasc Surg. 2022 Jan; 75: 4S-22S
        • Naylor A.R.
        • Gaines P.A.
        • Rothwell P.M.
        “Who benefits most from intervention for asymptomatic carotid stenosis: patients or professionals?”.
        Eur J Vasc Endovasc Surg. 2009; 37: 625-632
        • Holscher C.M.
        • Weaver M.L.
        • Black 3rd, J.H.
        • Abularrage C.J.
        • Lum Y.W.
        • Reifsnyder T.
        • et al.
        “Regional market competition is associated with aneurysm diameter at the time of EVAR.”.
        Ann Vasc Surg. 2020 Jul 29; S0890-5096: 30602-30606
        • Adler J.T.
        • Sethi R.K.V.
        • Yeh H.
        • Markmann J.F.
        • Nguyen L.L.
        “Market competition influences renal transplantation risk and outcomes.”.
        Ann Surg. 2014; 260: 550-557
      3. Society for Vascular Surgery Vascular Quality Initiative. “SVS VQI Procedures Collected.” Updated Jan 2020. https://www.vqi.org/about/vqi-procedures-collected/. Accessed Jul 2020.

      4. US Department of Health and Human Services. “Regional Offices.” Available from: https://www.hhs.gov/about/agencies/iea/regional-offices/index.html Accessed 9 May 2021.

        • Chang D.C.
        • Shiozawa A.
        • Nguyen L.L.
        • Chrouser K.L.
        • Perler B.A.
        • Freischlag J.A.
        • et al.
        “Cost of inpatient care and its association with hospital competition.”.
        J Am Coll Surg. 2011 Jan; 212: 12-19
        • Shean K.E.
        • McCallum J.C.
        • Soden P.A.
        • Deery S.E.
        • Schneider J.R.
        • Nolan B.W.
        • et al.
        “Regional variation in patient selection and treatment for carotid artery disease in the Vascular Quality Initiative (VQI).”.
        J Vasc Surg. 2017 Jul; 66: 112-121
        • Mukherjee D.
        • Liu C.
        • Jadali A.
        • Lewis E.
        • Neville R.
        “Effects of peripheral arterial disease interventions on survival: a propensity score matched analysis using VQI data.”.
        Ann Vasc Surg. 2022 Feb; 79: 162-173
        • Osborne Z.
        • Hanson K.
        • Brooke B.S.
        • Schermerhorn M.
        • Henke P.
        • Faizer R.
        • et al.
        “Variation in transfusion practices and the association of perioperative adverse events in patients undergoing open abdominal aortic aneurysm repair and lower extremity bypass in the Vascular Quality Initiative.”.
        Ann Vasc Surg. 2018 Jan; 46: 1-16
        • Schermerhorn M.L.
        • Liang P.
        • Dakour-Aridi H.
        • Kashyap V.S.
        • Wang G.J.
        • Nolan B.W.
        • et al.
        “In-hospital outcomes of transcarotid artery revascularization and carotid endarterectomy in the Society of Vascular Surgery Quality Initiative.”.
        J Vasc Surg. 2020 Jan; 71: 87-95
        • Hicks C.W.
        • Holscher C.M.
        • Wang P.
        • Black 3rd, J.H.
        • Abularrage C.J.
        • Makary M.A.
        “Overuse of early peripheral vascular interventions for claudication.”.
        J Vasc Surg. 2020 Jan; 71: 121-130.e1
        • Wasserman B.A.
        • Wityk R.J.
        • Troutill H.H.
        • RVirmani
        “Low-grade carotid stenosis: looking beyond the lumen with MRI.”.
        Stroke. 2005 Oct; 36: 2504-2513
        • Paraskevas K.I.
        • Veith F.J.
        • Spence J.D.
        “How to identify which patients with asymptomatic carotid stenosis could benefit from endarterectomy or stenting.”.
        Stroke Vasc Neurol. 2018 Jun; 3: 92-100
        • Keyhani S.
        • Cheng E.M.
        • Hoggatt K.J.
        • Austin P.C.
        • Madden E.
        • Hebert P.L.
        • et al.
        “Comparative effectiveness of carotid endarterectomy vs. initial medical therapy in patients with asymptomatic carotid stenosis.”.
        JAMA Neurol. 2020; 77: 1110-1121
        • Stoner M.C.
        • deFreitas D.J.
        “Process of care for carotid endarterectomy: perioperativ medical management.”.
        J Vasc Surg. 2010 Jul; 52: 223-231
        • Shean K.E.
        • O’Donnell T.F.X.
        • Deery S.E.
        • Pothof A.B.
        • Schneider J.R.
        • Rockman C.B.
        • et al.
        “Regional variation in patient outcomes in carotid artery disease treatment in the Vascular Quality Initiative.”.
        J Vasc Surg. 2018 Sep; 68: 749-759
        • Goodney P.P.
        • Travis L.L.
        • Malenka D.
        • Bronner K.K.
        • Lucas F.L.
        • Cronenwett J.L.
        • et al.
        “Regional variation in carotid artery stenting and endarterectomy in the Medicare population.”.
        Circ Cardiovasc Qual Outcomes. 2010 Jan; 3: 15-24
        • McPhee J.T.
        • Schanzer A.
        • Messina L.M.
        • Eslami M.H.
        “Carotid artery stenting has increased rates of postprocedure stroke, death, and resource utilization than does carotid endarterectomy in the United States, 2005.”.
        J Vasc Surg. 2008 Dec; 48: 1442-1450
        • Lichtman J.H.
        • Jones M.R.
        • Leifheit E.C.
        • Sheffet A.J.
        • Howard G.
        • Lal B.K.
        • et al.
        “Carotid endarterectomy and carotid stenting in the US Medicare population, 1999-2014.”.
        JAMA. 2017 Sep; 318: 1035-1046
      5. CMS.gov. Carotid artery stenting: CAG-00085R. Available from: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=157&ver=29&NcaName=Carotid+Artery+Stenting+(1st+Recon). Accessed Feb 16 2022.